Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1

Diabetes Care - United States
doi 10.2337/dc08-0935
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial-Type 1

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2009English

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

C-Peptide Reverses Nociceptive Neuropathy in Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Prevention of Type 1 Diabetes

Autoimmunity
AllergyImmunology
1995English

Increasing the Accuracy of Oral Glucose Tolerance Testing and Extending Its Application to Individuals With Normal Glucose Tolerance for the Prediction of Type 1 Diabetes: The Diabetes Prevention Trial-Type 1

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

Participant and Parent Experiences in the Oral Insulin Study of the Diabetes Prevention Trial for Type 1 Diabetes

Pediatric Diabetes
Internal MedicinePediatricsEndocrinologyPerinatologyChild HealthMetabolismDiabetes
2009English

C-Peptide Persistence in Type 1 Diabetes: ‘Not Drowning, but Waving’?

BMC Medicine
Medicine
2019English

Terbutaline and the Prevention of Nocturnal Hypoglycemia in Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2008English

Inverse Relationship Between Glomerular Hyperfiltration and C-Peptide Level in Type 1 Diabetes

Journal of Diabetes Mellitus
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy